530 related articles for article (PubMed ID: 36569912)
1. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis.
McCombe PA; Hardy TA; Nona RJ; Greer JM
Front Immunol; 2022; 13():1038411. PubMed ID: 36569912
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
Blum S; McCombe PA
J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
[TBL] [Abstract][Full Text] [Related]
3. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
4. Siponimod ameliorates experimental autoimmune neuritis.
Uchi T; Konno S; Kihara H; Fujioka T
J Neuroinflammation; 2023 Feb; 20(1):35. PubMed ID: 36788526
[TBL] [Abstract][Full Text] [Related]
5. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
6. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
7. The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
Jiao H; Ren H
Drug Des Devel Ther; 2018; 12():3817-3824. PubMed ID: 30464413
[TBL] [Abstract][Full Text] [Related]
8. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
McCombe PA; Csurhes PA; Greer JM
J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome.
Zhu J; Mix E; Link H
J Neuroimmunol; 1998 Apr; 84(1):40-52. PubMed ID: 9600707
[TBL] [Abstract][Full Text] [Related]
10. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L; Lleixà C
Neurotherapeutics; 2021 Oct; 18(4):2222-2235. PubMed ID: 34549385
[TBL] [Abstract][Full Text] [Related]
11. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
12. Animal models of autoimmune neuropathy.
Soliven B
ILAR J; 2014; 54(3):282-90. PubMed ID: 24615441
[TBL] [Abstract][Full Text] [Related]
13. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy.
Moalem-Taylor G; Allbutt HN; Iordanova MD; Tracey DJ
Brain Behav Immun; 2007 Jul; 21(5):699-710. PubMed ID: 17005365
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity in inflammatory autoimmune neuropathies.
Mäurer M; Toyka KV; Gold R
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S7-15. PubMed ID: 12690655
[TBL] [Abstract][Full Text] [Related]
15. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
16. CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Yuan F; Yosef N; Lakshmana Reddy C; Huang A; Chiang SC; Tithi HR; Ubogu EE
PLoS One; 2014; 9(3):e90463. PubMed ID: 24632828
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
18. Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis.
Shen D; Chu F; Lang Y; Geng Y; Zheng X; Zhu J; Liu K
Mediators Inflamm; 2018; 2018():4286364. PubMed ID: 29853789
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Allen D; Makowska A; Gregson NA
J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
[TBL] [Abstract][Full Text] [Related]
20. Acute/chronic inflammatory polyradiculoneuropathy.
Miranda C; Brannagan TH
Handb Clin Neurol; 2023; 195():619-633. PubMed ID: 37562890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
